yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33658593-DD4B4F94-77D7-44D2-8DAF-A81CD1589264
Q33658593-DD4B4F94-77D7-44D2-8DAF-A81CD1589264
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33658593-DD4B4F94-77D7-44D2-8DAF-A81CD1589264
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
P2860
Q33658593-DD4B4F94-77D7-44D2-8DAF-A81CD1589264
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33658593-DD4B4F94-77D7-44D2-8DAF-A81CD1589264
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
71af6fa2f5e063112783655ca43f697483ca1fb8
P2860
Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells.